Bayer: invests in the US biotech Triumvira
(CercleFinance.com) - Bayer announced on Thursday that it had participated in the final roundtable discussions of Triumvira, a Texan biotech company that raised some 55 million dollars in the deal.
The German giant says that it has taken this equity investment alongside Northpond Ventures, an investment fund specialising in life sciences and technology.
Based in Texas and also present in Canada, Triumvira created a cellular response platform that attacks cancer cells.
Bayer said that cancer prevention and treatment are now priority areas in its investments in start-ups.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
The German giant says that it has taken this equity investment alongside Northpond Ventures, an investment fund specialising in life sciences and technology.
Based in Texas and also present in Canada, Triumvira created a cellular response platform that attacks cancer cells.
Bayer said that cancer prevention and treatment are now priority areas in its investments in start-ups.
Copyright (c) 2020 CercleFinance.com. All rights reserved.